A Randomized, Double-Blind, Controlled Trial Comparing Rifaximin Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy

Effects of Rifaximin on Bacterial Virulence Mechanisms at Supra- and Sub-Inhibitory Concentrations

(2014) E.A. Debbia et al.   JOURNAL OF CHEMOTHERAPY

Small intestinal bacterial overgrowth and delayed orocecal transit time in patients with cirrhosis and low-grade hepatic encephalopathy

(2012) Manish Kumar Lunia et al.   Hepatology International

Rifaximinvsconventional oral therapy for hepatic encephalopathy: A meta-analysis

(2012) Karim M Eltawil   WORLD JOURNAL OF GASTROENTEROLOGY

Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy

(2010) Ankur Gupta et al.   JOURNAL OF HEPATOLOGY

Rifaximin Treatment in Hepatic Encephalopathy

(2010) Nathan M. Bass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rifaximin pharmacology and clinical implications

(2009) Veronica Ojetti et al.   Expert Opinion on Drug Metabolism & Toxicology

Rifaximin for Treatment of Hepatic Encephalopathy

(2008) Darego O Maclayton et al.   ANNALS OF PHARMACOTHERAPY

Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis

(2008) Qian Jiang et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Rifaximin for the Treatment of Hepatic Encephalopathy

(2008) Kenneth R Lawrence et al.   PHARMACOTHERAPY